Germaine Bergeron-Lynn Selected Research

1- O- hexadecyl- propanediol- 3- phospho- ganciclovir

2/2002

Treatment or prevention of herpes simplex virus retinitis with intravitreally injectable crystalline 1-O-hexadecylpropanediol-3-phospho-ganciclovir.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Germaine Bergeron-Lynn Research Topics

Disease

1	Choroidal Neovascularization 06/2004
1	Melanoma (Melanoma, Malignant) 09/2002
1	Uveal melanoma 09/2002
1	Neoplasms (Cancer) 09/2002
1	Cataract (Cataracts) 02/2002
1	Infections 02/2002
1	Retinitis 02/2002
1	Hyperoxia 01/2002
1	Retinal Diseases 01/2002
1	Hypoxia (Hypoxemia) 01/2002
1	Retinal Neovascularization 01/2002

Drug/Important Bio-Agent (IBA)

3	Pharmaceutical PreparationsIBA 06/2004 - 02/2002
2	prinomastat (Ag3340)IBA 06/2004 - 01/2002
1	Matrix Metalloproteinase InhibitorsIBA 06/2004
1	SuspensionsIBA 09/2002
1	Biological ProductsIBA 09/2002
1	Ammonium CompoundsIBA 02/2002
1	1- O- hexadecyl- propanediol- 3- phospho- ganciclovirIBA 02/2002
1	Antiviral Agents (Antivirals)IBA 02/2002
1	Retinaldehyde (Retinal)IBA 02/2002
1	SaltsIBA 02/2002
1	Metalloproteases (Metalloproteinases)IBA 01/2002
1	Oxygen (Dioxygen)IBA 01/2002

Therapy/Procedure

2	Lasers (Laser) 06/2004 - 09/2002
1	Semiconductor Lasers 06/2004
1	Injections 02/2002
1	Therapeutics 02/2002
1	Intravitreal Injections 02/2002
1	Intraperitoneal Injections 01/2002